Why is Kwality Pharma falling/rising?

As of 23-Sep, Kwality Pharmaceuticals Ltd is experiencing a price increase, with the current price at Rs 974.95, reflecting a rise of Rs 34.9 or 3.71%. Today's performance indicates that the stock has outperformed its sector by 4.06% and has shown a trend reversal after two consecutive days of decline. The stock reached an intraday high of Rs 983, and there has been a notable increase in investor participation, with delivery volume rising by 17.36% compared to the five-day average. Additionally, the stock has demonstrated strong performance over various periods, including a year-to-date return of 12.12% and a one-year return of 20.51%, significantly outperforming the broader market, which has seen negative returns.
In the broader market context, while the BSE500 index has generated negative returns of -4.69% over the past year, Kwality Pharmaceuticals has managed to achieve a positive return of 20.51%, indicating its resilience against market trends. The company's strong financial metrics, such as a low Debt to EBITDA ratio of 1.03 times and consistent positive results over the last six quarters, contribute to its favorable valuation. With a PEG ratio of 0.6 and a return on capital employed (ROCE) of 17.2%, the stock is trading at a discount compared to its peers, further supporting its upward price movement.